MedTrace Logo

Concentrations of Amiodarone in Fat Tissue During Chronic Treatment

NCT00313443 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2011-07-14

Study results available
· View outcomes & findings →

Summary

The objective of this study is to determine if concentrations of amiodarone in fat tissue increases constantly over time during chronic treatment with this drug, and if blood concentrations reflect accurately the concentrations in fat tissue or not. This is because excessive concentrations of this drug in tissues can produce adverse effects.

Conditions

Interventions

PROCEDURE

Fat tissue needle aspiration

Small fat tissue sampling performed by needle aspiration.

Sponsors & Collaborators

  • Unité de Recherches Therapeutiques - H. Lariboisiere

    collaborator UNKNOWN

  • Hopital Lariboisière

    lead OTHER

Principal Investigators

  • Carmelo Lafuente-Lafuente, MD · Hopital Lariboisière, Internal Medicine "A" Service, Paris

  • Jean-Francois Bergmann, MD · Hopital Lariboisiere, Internal Medicine "A" Service, Paris

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2006-04-30
Primary Completion
2007-10-31
Completion
2007-10-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00313443 on ClinicalTrials.gov